oxonic acid has been researched along with Bone Marrow Diseases in 2 studies
Oxonic Acid: Antagonist of urate oxidase.
Bone Marrow Diseases: Diseases involving the BONE MARROW.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although the preoperative chemotherapeutic regimen of S-1 and CDDP is regarded as effective, safe and well tolerable according to previous clinical study, we experienced a 74-year-old woman who suffered from life-threatening adverse events including severe myelosuppression during the neoadjuvant chemotherapy." | 1.35 | [Case report of gastric cancer patient who suffered life-threatening adverse events including severe myelosuppression during neoadjuvant chemotherapy with S-1 and CDDP combination]. ( Hashida, H; Kanai, M; Tada, M; Takabayashi, A; Ueda, S; Yoshida, M, 2008) |
| "The toxic effects of S-1 can lead to discontinuation of treatment." | 1.35 | Comparison of alternate-day versus consecutive-day treatment with S-1: assessment of tumor growth inhibition and toxicity reduction in gastric cancer cell lines in vitro and in vivo. ( Arai, W; Haruta, H; Hirashima, Y; Hosoya, Y; Hyodo, M; Kurashina, K; Nagai, H; Saito, S; Sakuma, K; Shirasaka, T; Yasuda, Y; Yokoyama, T; Zuiki, T, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ueda, S | 1 |
| Yoshida, M | 1 |
| Hashida, H | 1 |
| Tada, M | 1 |
| Takabayashi, A | 1 |
| Kanai, M | 1 |
| Arai, W | 1 |
| Hosoya, Y | 1 |
| Haruta, H | 1 |
| Kurashina, K | 1 |
| Saito, S | 1 |
| Hirashima, Y | 1 |
| Yokoyama, T | 1 |
| Zuiki, T | 1 |
| Sakuma, K | 1 |
| Hyodo, M | 1 |
| Yasuda, Y | 1 |
| Nagai, H | 1 |
| Shirasaka, T | 1 |
2 other studies available for oxonic acid and Bone Marrow Diseases
| Article | Year |
|---|---|
[Case report of gastric cancer patient who suffered life-threatening adverse events including severe myelosuppression during neoadjuvant chemotherapy with S-1 and CDDP combination].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Drug Combinat | 2008 |
Comparison of alternate-day versus consecutive-day treatment with S-1: assessment of tumor growth inhibition and toxicity reduction in gastric cancer cell lines in vitro and in vivo.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Bone Marrow Diseases; Cell Proliferation; Drug | 2008 |